Literature DB >> 25311856

Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score.

Marcello Di Nisio1,2, Michele Prisciandaro3, Anne W S Rutjes4, Ilaria Russi3, Luisa Maiorini3, Ettore Porreca3.   

Abstract

AIM: To assess the prevalence of vascular dementia, mixed dementia and Alzheimer's disease in patients with atrial fibrillation, and to evaluate the accuracy of the Hachinski ischemic score for these subtypes of dementia.
METHODS: A nested case-control study was carried out. A total of 103 of 784 consecutive patients evaluated for cognitive status at the Ambulatory Geriatric Clinic had a diagnosis of atrial fibrillation. Controls without atrial fibrillation were randomly selected from the remaining 681 patients using a 1:2 matching for sex, age and education.
RESULTS: The prevalence of vascular dementia was twofold in patients with atrial fibrillation compared with controls (21.4% vs 10.7%, P = 0.024). Alzheimer's disease was also more frequent in the group with atrial fibrillation (12.6% vs 7.3%, P = 0.046), whereas mixed dementia had a similar distribution. The Hachinski ischemic score poorly discriminated between dementia subtypes, with misclassification rates between 46% (95% CI 28-66) and 70% (95% CI 55-83). In patients with atrial fibrillation, these rates ranged from 55% (95% CI 32-77) to 69% (95% CI 39-91%). In patients in whom the diagnosis of dementia was excluded, the Hachinski ischemic score suggested the presence of vascular dementia in 11% and mixed dementia in 30%.
CONCLUSIONS: Vascular dementia and Alzheimer's disease, but not mixed dementia, are more prevalent in patients with atrial fibrillation. The discriminative accuracy of the Hachinski ischemic score for dementia subtypes in atrial fibrillation is poor, with a significant proportion of misclassifications.
© 2014 Japan Geriatrics Society.

Entities:  

Keywords:  Hachinski ischemic score; atrial fibrillation; dementia

Mesh:

Year:  2014        PMID: 25311856     DOI: 10.1111/ggi.12349

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  6 in total

Review 1.  Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.

Authors:  Heeyoung Lee; EunYoung Kim
Journal:  Arch Pharm Res       Date:  2020-09-09       Impact factor: 4.946

Review 2.  Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.

Authors:  Masafumi Ihara; Kazuo Washida
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 3.  Alzheimer's Disease and Cardiovascular Disease: A Particular Association.

Authors:  Giacomo Tini; Riccardo Scagliola; Fiammetta Monacelli; Giovanni La Malfa; Italo Porto; Claudio Brunelli; Gian Marco Rosa
Journal:  Cardiol Res Pract       Date:  2020-05-05       Impact factor: 1.866

4.  Atrial Fibrillation, Cognitive Decline And Dementia.

Authors:  Alvaro Alonso; Antonio P Arenas de Larriva
Journal:  Eur Cardiol       Date:  2016

5.  Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis.

Authors:  Christos A Papanastasiou; Christina A Theochari; Nikos Zareifopoulos; Angelos Arfaras-Melainis; George Giannakoulas; Theodoros D Karamitsos; Leonidas Palaiodimos; George Ntaios; Konstantinos I Avgerinos; Dimitrios Kapogiannis; Damianos G Kokkinidis
Journal:  J Gen Intern Med       Date:  2021-07-09       Impact factor: 6.473

Review 6.  Inflammatory and Infectious Processes Serve as Links between Atrial Fibrillation and Alzheimer's Disease.

Authors:  Gabriela Lopes Martins; Rita Carolina Figueiredo Duarte; Marat A Mukhamedyarov; András Palotás; Cláudia Natália Ferreira; Helton José Reis
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.